A national USC survey reveals that more than 25% of Americans believe they’re in no danger of being infected with COVID-19 in the next three months. The vast majority recognize the value of handwashing and sanitizing to keep themselves safe from infection. s the rate of COVID-19 infections in the United States continues to grow,
SARS-CoV-2 stability similar to original SARS virus. Source NIH What The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists in The New England Journal of Medicine. The scientists found
Since the first reports of novel pneumonia (COVID-19) in Wuhan, Hubei province, China, there has been considerable discussion on the origin of the causative virus, SARS-CoV-2 (also referred to as HCoV-19). Infections with SARS-CoV-2 are now widespread, and as of 17 March 2020, 190,664 cases have been confirmed in more than 155 countries, with 7,519 deaths.
A team of medical research and bioethics experts at Oxford University are supporting several European governments to explore the feasibility of a coronavirus mobile app for instant contact tracing. If rapidly and widely deployed, the infectious disease experts believe such an app could significantly help to contain the spread of coronavirus. The Oxford University team has provided
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) were able to test blood samples at four different time points in an otherwise healthy woman in her 40s, who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission. Published today in Nature Medicine is a detailed report of how the patient’s immune system
The explosive spread of the coronavirus in Wuhan, China, was driven by people whose disease was never diagnosed, a new study has found, suggesting that people with symptoms so mild that they may not have known they were sick unwittingly spread disease in China and ultimately around the world. Jeffrey Shaman, an infectious-disease expert at Columbia
The worst-case figures are what would happen if no action is taken to slow the virus, which spreads person to person. Disease modelers at the US Centers for Disease Control and Prevention project that as much as 65% of the American population could eventually be infected by the new coronavirus, according to the New York Times.
A letter, recently published on Lancet, suggests that ACE inhibitors, ARBs and ibuprofen results in upregulation of ACE2 receptors. Human pathogenic coronaviruses (severe acute respiratory syndrome coronavirus [SARS-CoV] and SARSCoV-2) bind to their target cells through angiotensin-converting enzyme 2 (ACE2), which is expressed by epithelial cells of the lung, intestine, kidney, and blood vessels. The
INFUSIONS OF ANTIBODY-LADEN BLOOD HAVE BEEN USED WITH REPORTED SUCCESS IN PRIOR OUTBREAKS, INCLUDING THE SARS EPIDEMIC AND THE 1918 FLU PANDEMIC Countries fighting outbreaks of the novel coronavirus disease COVID-19 should consider using the antibodies of people who have recovered from infection to treat cases and provide short-term immunity—lasting weeks to months—to critical health care
Pluristem Therapeutics Inc., a leading regenerative medicine company developing a platform of novel biological products, today announced it has signed a collaborative agreement with the BIH Center for Regenerative Therapy (BCRT) and the Berlin Center for Advanced Therapies (BeCAT) at Charite’ University of Medicine Berlin to expand its existing framework and research agreement and conduct
